CDMO
T. Rowe Price Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-36,753
| Closed | -$454K | – | 3092 |
|
|
2024
Q4 | $454K | Buy |
36,753
+3,427
| +10% | +$42.3K | ﹤0.01% | 2319 |
|
|
2024
Q3 | $380K | Buy |
33,326
+294
| +0.9% | +$3.35K | ﹤0.01% | 2370 |
|
|
2024
Q2 | $236K | Buy |
33,032
+2,733
| +9% | +$19.5K | ﹤0.01% | 2527 |
|
|
2024
Q1 | $204K | Buy |
30,299
+1,649
| +6% | +$11.1K | ﹤0.01% | 2618 |
|
|
2023
Q4 | $187K | Buy |
28,650
+2,535
| +10% | +$16.5K | ﹤0.01% | 2565 |
|
|
2023
Q3 | $247K | Buy |
26,115
+1,367
| +6% | +$12.9K | ﹤0.01% | 2417 |
|
|
2023
Q2 | $346K | Buy |
24,748
+872
| +4% | +$12.2K | ﹤0.01% | 2298 |
|
|
2023
Q1 | $448K | Buy |
23,876
+693
| +3% | +$13K | ﹤0.01% | 2159 |
|
|
2022
Q4 | $319K | Buy |
23,183
+1,009
| +5% | +$13.9K | ﹤0.01% | 2347 |
|
|
2022
Q3 | $424K | Buy |
22,174
+3,885
| +21% | +$74.3K | ﹤0.01% | 2208 |
|
|
2022
Q2 | $279K | Buy |
18,289
+400
| +2% | +$6.1K | ﹤0.01% | 2469 |
|
|
2022
Q1 | $364K | Buy |
17,889
+1,442
| +9% | +$29.3K | ﹤0.01% | 2463 |
|
|
2021
Q4 | $480K | Buy |
+16,447
| New | +$480K | ﹤0.01% | 2395 |
|